Skip to the page

Data / Form D filings / Los Angeles Biosciences, Inc.

Los Angeles Biosciences, Inc.: Form D filing

Los Angeles Biosciences, Inc., a health care company in Playa Del Rey, CA, filed a Form D with the SEC in 2025. The latest, on June 24, 2025, reports $4.9 million sold of a $5 million offering to 17 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
419 WATERVIEW STREET, Playa Del Rey, CA, 90293
Phone
(907) 350-7848
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2074477

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 24, 2025New notice$5,000,000$4,869,444$130,55617Jun 9, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jeff L. NicholsExecutive Officer
Derya L. KelterExecutive Officer, Director
Ketan L. PatelDirector

Other health care companies in California that filed recently

Every Form D from the week of Jun 23, 2025 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Los Angeles Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.